NYXH Nyxoah
Company Analysis
Latest News
🔴 Nyxoah is trading 5% down today with no clear catalyst identified
Nyxoah is trading 5.03% down at $1.13 on October 16, with no clear catalyst identified. - Nyxoah closed at $1.19 on October 15, down 4.80%. - A proposed $50...
🔴 Nyxoah is trading 6% down today as oil and Treasury yields rise
Nyxoah is trading 5.99% down at $1.33 on October 8, 2026, amid broad risk-off pressure. - No same-day company announcement explaining the decline surfaced in...
🟢 Nyxoah is trading 5% up with no confirmed catalyst
Nyxoah is trading at $1.43, up 5.15%, on October 5, with its specific driver unconfirmed. - Nyxoah’s recent CEO appointment took effect October 1; that...
🟢 Nyxoah is trading 11.28% up in pre-market with no confirmed company-specific catalyst
Nyxoah is trading at $1.48, up 11.28%, with no fresh company-specific announcement identified to explain its October 2 pre-market rise. - Nyxoah’s previously...
🔴 Nyxoah is trading 10.1% down
Nyxoah is trading at $1.43, down -10.06%, with no confirmed company-specific catalyst identified for the September 29 decline. - Nyxoah announced Liam Kelly’s...
🔴 Nyxoah is trading 6.2% down; reason remains unclear
Nyxoah is trading at $1.49, down 6.21%, with no confirmed catalyst identified for the September 29 decline. - Nyxoah announced Liam Kelly’s appointment as CEO...
🔴 Nyxoah is trading 5% down in pre-market with no confirmed catalyst
Nyxoah is trading 5.03% lower at $1.51 in pre-market; no new company-specific catalyst has been identified. - Nyxoah announced Liam Kelly’s appointment as CEO...
Nyxoah Names Liam Kelly CEO to Drive U.S. Growth After Genio Approval
Nyxoah named Liam Kelly its new chief executive officer, effective October 1, 2026. Kelly will succeed Olivier Taelman as the medical technology company steps...
🟢 Nyxoah is trading 10.69% up as the specific driver remains unclear
Nyxoah is trading 10.69% up at $1.60 on September 28, 2026, with no clear company-specific catalyst identified. - The latest company news was a September 21...
🟢 Nyxoah is trading 9% up
Nyxoah is trading at $1.58, up 8.97% in live trading on September 28, 2026, with no clear company-specific catalyst identified. - The latest company...
🟢 Nyxoah is trading 10% up in pre-market
Nyxoah is trading 10.34% higher at $1.60 in pre-market on September 28, with no clear company-specific catalyst identified. - The latest company announcement...
🟢 Nyxoah is trading 6.9% up in pre-market with no clear catalyst identified
Nyxoah is trading 6.9% higher at $1.55 in pre-market on September 28; no clear company-specific announcement explaining the move was identified. - The latest...
🟢 Nyxoah is trading 10.6% up today as healthcare stocks gain
Nyxoah is trading at $1.41, up 10.6%, as healthcare stocks gain amid renewed biotechnology optimism, acquisition activity, and a supportive regulatory...
🟢 Nyxoah is trading 8.7% up today as healthcare gains 1.27%
Nyxoah is trading at $1.38, up 8.66%, with the move appearing mainly sector-driven. - Healthcare gained 1.27% as renewed biotech optimism, acquisition activity...
🟢 Nyxoah is trading 7.09% up in pre-market
Nyxoah is trading 7.09% higher at $1.36, with no clear company-specific catalyst identified. - Nyxoah closed at $1.27 on September 24, 2026; no clear...
🔴 Nyxoah is trading 5.36% down today as U.S. markets fall
Nyxoah is trading at $1.32 (-5.36%) as U.S. markets fall, creating a risk-off backdrop. - The S&P 500 is down 0.65%, while the Nasdaq is down 1.06%. - Higher...
🟢 Nyxoah is trading 5% up in after-hours trading after CFO departure announcement
Nyxoah is trading 5% up at $1.47 after its September 21, 2026 announcement that CFO John Landry will depart. - Landry’s departure is effective October 2....
🔴 Nyxoah is trading 5% down today after CFO departure effective October 2, 2026
Nyxoah is trading 5% down at $1.41 after CFO John Landry announced his departure, effective October 2, 2026. - Loïc Moreau, the company’s former CFO, will...
🔴 Nyxoah is trading 5.8% down in after-hours trading with no company-specific catalyst identified
Nyxoah is trading 5.81% down now at $1.46 after no new company-specific announcement or earnings release was identified for September 16, 2026. - Earlier...
Cantor Fitzgerald Reiterates Overweight Rating Following Positive Trial Results
Cantor Fitzgerald reiterated its Overweight rating and $6.00 price target for Nyxoah SA on September 4, 2026. The affirmation follows the company's...